FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.
Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach.
Clinical Trial M-13-027: Evaluation of Clinical Outcomes Following Treatment with Systane® Balance in Dry Eye Subjects with Lipid Deficiency
Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma
JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion
TREND: A phase IIIb, randomized, a 12-month, Visual Acuity assessor-masked, interventional study assessing the efficacy and safety of the Treat and Extend vs monthly regimens of 0.5 mg ranibizumab in patients with newly diagnosed nAMD
MACBETH. Phase IV Study to evaluate the efficacy of aflibercept in subjects with neovascular Age-related Macular Degeneration (wAMD), without optimal response to repeated monthly intravitreal injections of Anti Vascular Endothelial Growth Factor (Anti VEGF-A) Therapy